Citigroup
IMGN

Citigroup’s Immunogen Inc IMGN Stock Holding History

Citigroup’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,000
Closed -$48K – 7839
2019
Q3 		$48K Sell
20,000
-1,200
-6% -$3.19K ﹤0.01% 6156
2019
Q2 		$46K Sell
21,200
-19,700
-48% -$46.6K ﹤0.01% 6561
2019
Q1 		$111K Buy
40,900
+28,000
+217% +$121K ﹤0.01% 5648
2018
Q4 		$62K Sell
12,900
-2,700
-17% -$16.4K ﹤0.01% 6064
2018
Q3 		$148K Sell
15,600
-200
-1% -$1.92K ﹤0.01% 5534
2018
Q2 		$154K Buy
15,800
+14,800
+1,480% +$156K ﹤0.01% 5309
2018
Q1 		$11K Buy
+1,000
New +$9.88K ﹤0.01% 7030

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's IMGN Position: Q1 2024 in Review

Citigroup sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 337,743 shares — an estimated $10M sold.

Citigroup first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $10M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Citigroup reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Citigroup sold 337,743 Immunogen Inc shares in Q1 2024, an estimated $10M.
  • Citigroup first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Citigroup's Immunogen Inc position peaked at $10M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.